Investor Determination to Beat Cancer Puts NeOnc’s Novel Therapies and Patented Platform in Focus

Go back to Investor Determination to Beat Cancer Puts NeOnc’s Novel Therapies and Patented Platform in Focus
(NASDAQ: NTHI) Delayed: 2.90 +0.13 (4.69%)
Previous Close $2.77    52 Week High $ 
Open $2.80    52 Week Low $ 
Day High $2.96    P/E N/A 
Day Low $2.75    EPS $ 
Volume 106,149